United States Direct-To-Consumer
Genetic Testing Market is expected to grow at a significant rate during the
forecast period, 2024-2028. During
the forecast period, rising public awareness of the accessibility of
direct-to-consumer genetic tests in both developed and developing countries
will fuel market expansion. Leading market players have concentrated on
creating top-notch direct-to-consumer genetic testing solutions. These tests
guarantee accurate and reliable genetic test results. The global
Direct-To-Consumer (DTC) Genetic Testing Market is driven by this. Moreover,
businesses such as 23andMe have made special marketing efforts to advertise
their direct-to-consumer genetic tests through offline and online retail
pharmacies. Moreover, businesses advertise their goods with appealing discounts
and promotional offers.
Genetic testing refers to
medical procedures that examine alterations in genes, chromosomes, or proteins
in an effort to either confirm or disprove the existence of a genetic disorder
or to estimate a person's propensity to do so. Through direct-to-consumer
genetic testing, customers may be able to receive genetic tests with little or
no participation from a third-party healthcare professional. Online or printed
advertisements are used to offer direct-to-consumer genetic testing kits to
potential customers. DTC genetic testing became available in the early 2000s,
enabling consumers to collect genetic data without a doctor's assistance. The
exams can be purchased offline or online through distribution outlets.
Rising Demand for Personalized Direct-To-Consumer
Genetic Testing Services Fuel Market Expansion
The statistics of the
direct-to-consumer genetic testing market will profit from the pharmacogenetics
field's rising popularity. One well-known use of gene-based personalization is
in the field of pharmacogenetics, in which genetic variations determine the
selection of a drug therapy that support the growth of a company. Furthermore,
the evaluation and control of individualized tests is done through consumer
comprehension. The service provider gives descriptive data on the test's
analytic and clinical validity, which raises industry demand. Additionally, the
cost of these customized testing is lower than that of conventional genetic
examinations. Moreover, findings from customized direct-to-consumer genetic
tests can be promptly acquired using easy-to-use, non-invasive techniques. The
aforementioned factors are anticipated to increase the direct-to-consumer
genetic testing market share overall.
Rising Public Awareness Regarding
Direct-To-Consumer (DTC) Genetic Testing is Driving Market Expansion
The rapid growth of
direct-to-consumer genetic testing is being aided by the rise in the frequency
of chronic diseases as well as the advent of customized testing kits for specialized
therapeutic fields. The acceptance and modification of such services has boosted
the demand for such kits. Moreover, government awareness programs in the region
are expected to boost awareness among individuals which in turn drives the
growth of the market throughout the forecast period. Furthermore, the availability
of these kits on online platforms is expected to support the growth of the Direct-To-Consumer
(DTC) Genetic Testing market during the forecast period 2024-2028.
High Cost of DTC Kits is Hampering
the Growth of the US Direct-To-Consumer (DTC) Genetic Testing Market
High cost of DTC genetic
testing services is limiting the growth of the US Direct-To-Consumer Genetic
testing market. Various manufacturers are focusing on product advancement &
innovation, and the integration of next-generation technologies to launch
high-end direct-to-consumer tests, leading to high investment in manufacturing
facilities along with high product prices. For instance, based on the
complexity of the test and the severity of the disease, and the cost of direct-to-consumer
genetic tests varies form USD 100 to USD 3,000. Hence, the demand for genetic
services across middle-income and developed regions in the United States is
anticipated to limit the growth of the market.
Download Free Sample Report
Market Segmentation
United States Direct-To-Consumer Genetic
Testing Market is segmented based on test
type, technology, and sample. Based on product & services,
the market is divided into ancestry &
relationship testing, predictive testing, nutrigenomic testing, carrier
testing, skincare testing, and others.
Based on technology, the market is further divided into Single Nucleotide
Polymorphism (SNP) chips, targeted analysis, Whole Genome Sequencing (WGS), and
Others. On the basis of sample, the market is further split into saliva, urine,
blood, and others. Based on distribution channel, the market is divided into online
and offline.
Market players
Ancestry.com, LLC, Helix OpCo LLC, MyHeritage
Ltd., Living DNA, and Direct Laboratory Services, LLC are the major players
operating in the United States Direct-to-Consumer Genetic Testing Market.
Attribute
|
Details
|
Base Year
|
2022
|
Historic
Data
|
2018 – 2021
|
Estimated
Year
|
2023
|
Forecast
Period
|
2024 – 2028
|
Quantitative
Units
|
Revenue in USD Million and CAGR for 2018-2022 and 2023-2028
|
Report
coverage
|
Revenue
forecast, company share, competitive landscape, growth factors, and trends
|
Segments
covered
|
By Test Type
By Technology
By Sample
By Distribution
Channel
|
Regional
scope
|
North-East,
Mid-West, West, South
|
Key
companies profiled
|
Ancestry.com, LLC, Helix OpCo LLC, MyHeritage Ltd., Living DNA,
Direct Laboratory Services, LLC
|
Customization
scope
|
10% free
report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
Pricing
and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
Delivery
Format
|
PDF
and Excel through Email (We can also provide the editable version of the
report in PPT/Word format on special request)
|
Report Scope:
In this report, the United States Direct-To-Consumer
Genetic Testing Market has been segmented into the following categories, in
addition to the industry trends which have also been detailed below:
- United States Direct-To-Consumer
Genetic Testing Market, By Test Type:
- Ancestry & Relationship Testing
- Predictive Testing
- Nutrigenomic Testing
- Carrier Testing
- Skincare Testing
- Others
- United States Direct-To-Consumer
Genetic Testing Market, By Technology:
- Single Nucleotide Polymorphism (SNP) Chips
- Targeted Analysis
- Whole Genome Sequencing (WGS)
- Others
·
United States Direct-To-Consumer
Genetic Testing Market, By Sample
o Saliva
o Urine
o Blood
o Others
·
United States Direct-To-Consumer
Genetic Testing Market, By Distribution
Channel
o Online
o Offline
·
United States Direct-To-Consumer Genetic Testing
Market, By Region
o North-East
o Mid-West
o West
o South
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in the United States Direct-To-Consumer
Genetic Testing Market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following customization
options are available for the report:
Company
Information
- Detailed analysis and profiling of additional market players (up to
five).
United States Direct-To-Consumer
Genetic Testing Market is an upcoming report to be released soon. If you wish
an early delivery of this report or want to confirm the date of release, please
contact us at [email protected]